Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2011
  • Online publication date: October 2011

Chapter 6 - Dementia and epilepsy


AlaTA, BehGO, FreyWH. Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer's disease. Neurology 2000; 54:843–8.
AmatniekJC, HauserWA, DelCastillo-CastanedaC, et al. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 2006; 47:867–72.
ArmonC, PetersonGW, LiwniczBH. Alzheimer's disease underlies some cases of complex-partial status epilepticus. J Clin Neurophysiol 2000; 17:511–18.
BeyreutherBK, FreitagJ, HeersC, et al. Lacosamide: a review of preclinical properties. CNS Drug Rev 2007; 13:21–42.
BrodieMJ, OverstallPW, GiorgiL. The UK Lamotrigine Elderly Study Group: multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999; 37:81–7.
CaramelliP, CastroLHM. Dementia associated epilepsy. Intern Psychogeriatr 2005; 17:S195-S206.
ChandlerJD, ChandlerJE. The prevalence of neuropsychiatric disorders in a nursing home. J Geriatr Psychiatry Neurol 1988; 1:71–6.
ClearyP, ShorvonS, TallisR. Late-onset seizures as a predictor of subsequent stroke. Lancet 2004; 363:1184–6.
De la CourtA, BretelerMMB, MeinardiH, et al. Prevalence of epilepsy in the elderly: the Rotterdam study. Epilepsia 1996; 37:141–7.
De RonchiD, BerardiD, MenchettiM, et al. Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. Dement Geriatr Cogn Disord 2005; 19:97–105.
EzquerraM, CarneroC, BlesaR, et al. A presenilin 1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures. Neurology 1999; 52:566–70.
FerrendelliJA, FrenchJ, LeppikI, et al. Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial. Epilepsy Behav 2003; 4:702–9.
FillenbaumGG, HeymanA, HuberMS, et al. The prevalence and 3-year incidence of dementia in older Black and White community residents. J Clin Epidemiol 1998; 51(7):587–95.
ForstlH, BurnsA, LevyR, et al. Neurologic signs in Alzheimer's disease: results of a prospective clinical and neuropathologic study. Arch Neurol 1992; 49:1038–42.
FritzN, GlogauS, HoffmannJ, et al. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav 2005; 6(3):373–81.
GentonP, PagliaG. Epilpesie myoclonic senile? Myoclonies d'àpparition tardive dans le syndrome de Down. Epilepsies 1994; 1:5–11.
HauserWA. Seizure disorders: the changes with age. Epilepsia 1992; 33 (Suppl 4):S6–14.
HauserWA, MoriisML, Heston, LL, AndersonVE. Seizures and myoclonus in patients with Alzheimer's disease. Neurology 1986; 36:1226–30.
HauserWA, AnnegersJH, KurlandLT. The incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia 1993; 34:453–68.
HelmerC, PeresK, LetenneurL, et al. Dementia in subjects aged 75 years or over within the PAQUID cohort: prevalence and burden by severity. Dement Geriatr Cogn Disord 2006; 22:87–94.
HendersonAS. Epidemiology of dementia disorders. Adv Neurol 1990; 51:15–25.
HessdorferDC, HauserWA, AnnegersJF, et al. Dementia and adult-onset unprovoked seizures. Neurology 1996; 46:727–30.
HeymanA, WilkinsonWE, HurwitzBJ, et al. Early onset Alzheimer's disease: clinical predictors of institutionalization and death. Neurology 1987; 37:980–4.
HommetC, MondonK, CamusV, et al. Epilepsia and dementia in the elderly. Dement Geriatr Cogn Disord 2008; 25(4):293–300.
International League Against Epilepsy. Commission report: the epidemiology of the epilepsies: future directions. Epilepsia 1997; 38:614–18.
JanssenJC, HallM, FoxNC, et al. Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation: a clinicopathological study. Brain 2000; 123:894–907.
LarnerAJ. Epileptic seizures in AD patients. Neuromolecular Med 2010; 12(1):71–7.
LarnerAJ, DoranM. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J Neurol 2006; 253:139–58.
LiLM, O'DonoghueMF, SanderJW. Myoclonic epilepsy of late onset in trisomy 21. Arquivos de Neuropsiquiatrica 1995; 53:792–4.
LozsadiDA, LarnerAJ. Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer's disease. Dementia Geriatr Cogn Disord 2006; 22:121–4.
MattsonRH, CramerJA, JosephBS, et al. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic–clonic seizures in adults. N Engl J Med 1992; 327:765–71.
McAreaveyMJ, BallingerBR, FentonGW. Epileptic seizures in elderly patients with dementia. Epilepsia 1992; 33:657–60.
MendezMF, LimGTH. Seizures in elderly patients with dementia. Drug Aging 2003; 20(11):791–803.
MendezMF, CatanzaroP, DossRC, et al. Seizures in Alzheimer's disease: clinicopathologic study. J Geriatr Psychiatry Neurol 1994; 7:230–3.
MinkevicieneR, RheimsS, DobszayMB, et al. Amyloid-β-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 2009; 29:3453–62.
PackAM, OlarteLS, MorrellMJ, et al. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav 2003; 4:169–74.
PalopJJ, MuckeL. Epilepsy and cognitive impairment in Alzheimer disease. Arch Neurol 2009; 66:435–40.
Pohlmann-EdenB. Issues when treating epilepsy in the elderly. Acta Neurol Scand Suppl 2005; 181:40–6.
Pohlmann-EdenB, NewtonM.First Seizure: EEG and neuroimaging following an epileptic seizure. Epilepsia 2008; 49 (Suppl 1):19–25.
Pohlmann-EdenB, CochiusJI, HochBD, HennericiM.Stroke and epilepsy: risk factors, pathophysiology and overlap syndromes. Cerebrovasc Dis 1997; 7:2–9.
PuriBK, HoKW, SinghI. Age of seizure onset in adults with Down syndrome. Intern J Clin Pract 2001; 55:442–4.
RamarosonH, HelmerC, Barberger-GateauP, et al. Prevalence of dementia and Alzheimer's disease among subjects aged 75 years or over: updated results of the PAQUID cohort. Rev Neurol (Paris) 2003; 159:405–11.
RamsayRE, RowanJ, PryorFM. Special considerations in treating the elderly patient with epilepsy. Neurology 2004; 62(Suppl 2):S24–S29.
RaoSC, DoveG, CascinoGD, PetersenRC. Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome. Epilepsy Behav 2009; 14:118–20.
RisseSC, LampeTH, BirdTH, et al. Myoclonus, seizures and paratonia in Alzheimer's disease. Alzheimer Dis Assoc Disord 1990; 4:217–25.
RomanelliMF, MorrisJC, AshkinK, CobenLA. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 1990; 47:847–50.
RowanAJ, RamsayRE, CollinsJF, et al. VA Cooperative Study 428 Group. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005; 64(11):1868–73.
SandersKM, MurrayGB. Geriatric epilepsy: a review. J Geriatr Psychiatry Neurol 1991; 4:98–105.
ScarmeasN, HonigLS, ChoiH, et al. Seizures in Alzheimer Disease: who, when, and how common?Archiv Neurol 2009; 66:992–7.
SchreinerA, Pohlmann-EdenB, SchwartzA, HennericiM. Epileptic seizures in subcortical vascular encephalopathy. J Neurol Sci 1995; 130:171–7.
StephenLJ, BrodieMJ. Epilepsy in elderly people. Lancet 2000; 355:1441–6.
TakaoM, GhettiB, MurrellJR, et al. Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures. J Neuropathol Exp Neurol 2001; 60:1137–52.
TallisR, HallG, CraigI, DeanA. How common are epileptic seizures in old age?Age Ageing 1991; 20:442–8.
Velez-PardoC, ArellanoJI, Cardona-GomezP, et al. CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy. Epilepsia 2004; 45:751–6.
VolicerL, SmithS, VolicerBJ. Effect of seizures on progression of dementia of the Alzheimer type. Dementia 1995; 6:258–63.
WeinerMF, HynanLS, ParikhB, et al. Can Alzheimer's disease and dementia with Lewy bodies be distinguished clinically?J Geriatr Psych Neurol 2003; 16:245–50.